Literature DB >> 19480249

Risk of malignancy index for adnexal masses.

N Akdeniz1, U Kuyumcuoğlu, A Kale, M Erdemoğlu, F Caca.   

Abstract

OBJECTIVES: The aim of this study was to determine the effectiveness of the risk of malignancy index (RMI) and retrospective analysis of patients presenting with adnexal masses to our clinic for treatment.
METHODS: Data of 137 women who had adnexal masses were included in the analysis. A simple algorithm called "risk of malignancy index" (RMI) reported by Jacobs includes menopausal status, ultrasound morphologic features and serum CA125 level. The RMI values were detected for each patient and analyzed to detect the relationship between benign and malign groups of the patients. Statistical analyses were performed with SPSS 15.0 for Windows (SPSS, Inc., Chicago, IL USA). Sensitivity and specificity was calculated for RMI in diagnoses of ovarian cancer by using receiver operating characteristic (ROC) analysis.
RESULTS: A total of 137 patients with adnexal masses were operated on. Mean age and SD of 137 patients were 30.64 +/- 10.05. Fourteen patients (10.2%) had malignant disease and 123 patients (89.8%) benign pathology. ROC analysis of the RMI showed that the values of area under the curve were significantly high with a value of 0.883 (p < 0.001).
CONCLUSION: The RMI is a simple scoring system and has a high sensitivity and specificity for the detection of malignant adnexal masses. Application of the RMI in clinical practice may provide a rational basis for specialists to treat patients with adnexal masses before diagnostic surgery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19480249

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  5 in total

1.  Diagnostic value of risk of malignancy index in the clinical evaluation of ovarian mass.

Authors:  Ali Huwidi; Afaf Abobrege; Mourad Assidi; Abdelbaset Buhmeida; Eramah Ermiah
Journal:  Mol Clin Oncol       Date:  2022-05-30

2.  Risk of malignancy index as an evaluation of preoperative pelvic mass.

Authors:  Zinatossadat Bouzari; Shahla Yazdani; Ziba Shirkhani Kelagar; Narges Abbaszadeh
Journal:  Caspian J Intern Med       Date:  2011

3.  Comparison of three malignancy risk indices and CA-125 in the preoperative evaluation of patients with pelvic masses.

Authors:  Zinatossadat Bouzari; Shahla Yazdani; Mahmoud Haji Ahmadi; Shahnaz Barat; Ziba Shirkhani Kelagar; Maryam Javadian Kutenaie; Nargeuss Abbaszade; Fateme Khajat
Journal:  BMC Res Notes       Date:  2011-06-20

4.  Is Risk Malignancy Index a Useful Tool for Predicting Malignant Ovarian Masses in Developing Countries?

Authors:  Aliya B Aziz; Nida Najmi
Journal:  Obstet Gynecol Int       Date:  2015-06-21

5.  A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.

Authors:  Santosh Kumar Dora; Atal Bihari Dandapat; Benudhar Pande; Jatindra Prasad Hota
Journal:  J Ovarian Res       Date:  2017-08-14       Impact factor: 4.234

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.